Triple #combination of #Remdesivir, #Molnupiravir & #Ribavirin is highly efficient in inhibiting #coronavirus #replication in #human nasal #airway epithelial cell cultures & in a #hamster infection model. Antiviral Res.: https://www.sciencedirect.com/science/article/pii/S0166354224002031?via%3Dihub

Combining Remdesivir, molnupiravir, & ribavirin increases the antiviral efficacy against coronavirus OC43. This triple therapy also eliminates #SARS-CoV-2 replication in #lungs of infected hamsters, unlike double combinations.

The triple #combination of #Remdesivir (GS-441524), #Molnupiravir and #Ribavirin is highly efficient in inhibiting #coronavirus #replication in human nasal #airway epithelial #cell cultures and in a hamster infection model http://biorxiv.org/cgi/content/short/2024.05.14.594200v1?rss=1

Our finding indicate that co-administration of approved drugs for treatment of CoVs infections should be further explored but also vs other families of viruses w/ epidemic and pandemic potential for which no effective antiviral treatment is available.